NEWS: 公告在東京證券交易所JASDAQ標準市場新上市



Next-generation Robotic Technologies for Minimally Invasive Surgical Applications

出版商 Frost & Sullivan 商品編碼 950637
出版日期 內容資訊 英文 51 Pages
商品交期: 最快1-2個工作天內
適用於微創手術應用的下一代機器人技術 Next-generation Robotic Technologies for Minimally Invasive Surgical Applications
出版日期: 2020年06月29日內容資訊: 英文 51 Pages





  • 調查範圍
  • 調查方法


  • 機器人手術比例的變化
  • 通過提高性能並減少與手術相關的併發症來擴大手術機器人系統的使用
  • 通過提高下一代手術機器人系統的實用性,為擴大採用率做出貢獻


  • 基於下一代手術機器人系統類型的技術細分
  • 單口機器人手術系統
  • 機器人自然開放腔內窺鏡手術系統
  • 多端口機器人手術系統


  • 評估政府對下一代手術機器人系統的資助
  • NIH對下一代手術機器人系統的資金分析
  • National Heart、Lung、and Blood Institute下一代外科手術機器人系統技術研究
  • Titan Medical與Teleflex的合作
  • Medtronic和KARL STORZ結盟
  • Johnson&Johnson收購Verb Surgical
  • Johnson&Johnson收購Orthotaxy
  • 應用分析
  • 下一代手術機器人的採用評估
  • 中國:下一代手術機器人系統的創新
  • 中國:政府支持政策以支持下一代手術機器人創新
  • 專利方案:下一代手術機器人的關鍵專利


  • 由於住院率低和付款模式靈活,提高了機器人手術的採用率
  • 戰略建議


  • 行業主要聯繫人


Product Code: D984

Innovations in Robotic-assisted Single-port, Multi-port and Natural Orifice Transluminal Endoscopic Surgery Changing Industry Dynamics

Novel characteristics of next-generation surgical robots have helped in addressing the limitations of traditional robotic systems, enabling their increased adoption in operating rooms. These platforms offer features such as enhanced ergonomic design and visualization, while maintaining the advantages of minimally invasive surgery. Incorporation of advanced technologies such as haptic feedback, biometric integration including eye tracking cameras, or head-tracking robotic arms facilitates completion of complex surgical tasks with greater precision.

This research service highlights the innovations in next-generation surgical robotic platforms including single port robotic surgery systems, robotic natural orifice transluminal endoscopic surgery systems, and multiport robotic surgery systems. The research service discusses the impact of these innovations, growth opportunities, funding, recent partnerships, and acquisitions.

Table of Contents

1.0. Executive Summary

  • 1.1. Scope of the Research
  • 1.2. Research Methodology
  • 1.3. Research Methodology (continued)

2.0. Industry Overview

  • 2.1. Trends in the Proportional Use of Robotic Surgeries
  • 2.2. Enhanced Performance and Reduced Procedure-related Complications have Enabled Greater Use of Surgical Robotic Systems
  • 2.3. Enhanced Utility of Next-generation Surgical Robotic Systems Contributing to its Greater Adoption

3.0. Technology Snapshot

  • 3.1. Technology Segmentation Based on Type of Next-generation Surgical Robotic Systems
  • 3.2. Single-port Robotic Surgery Systems
    • 3.2.1. Robotic Surgical System Designed for Quick Operating Room Setup
    • 3.2.2. Robotic System for Providing Enhanced Precision and Control during Lateral Oropharyngectomy and Urology Procedures
    • 3.2.3. Compact and Highly Dexterous Robotic Surgical System for Precise Colon Resection Surgery
    • 3.2.4. Growth Opportunities: Smaller Profile, Improved Operating Room Efficiency and Enhanced Anatomical Access to Spur Adoption of Single-port Systems
  • 3.3. Robotic Natural Orifice Transluminal Endoscopic Surgery Systems
    • 3.3.1. Robotic Surgical System for Accurate Detection and Treatment of Lung Tumors
    • 3.3.2. Robotic Surgical System for Enabling Faster Removal of Gastrointestinal Tumors
    • 3.3.3. Robotic Surgical System for Accessing Distant Anatomical Regions
    • 3.3.4. Growth Opportunities: Ergonomic Design, Enhanced Anatomical Accessibility and Short Learning Curve to Improve Use of these Platforms
  • 3.4. Multi-port Robotic Surgery Systems
    • 3.4.1. Robotic Surgical System for High-precision Vitreoretinal Procedures
    • 3.4.2. Portable Robotic Surgical System that Improves Hospitals' Efficiency and Patient Throughput
    • 3.4.3.Robotic Surgical System with Advanced Controls for Improving Patient and Surgeon Experience
    • 3.4.4. Growth Opportunities: Reducing Procedural Complications, Lower Cost of Instrumentation and Easier Integration with Existing Operating Room Surgical Systems to Drive Adoption of these Platforms

4.0. Funding and Impact Assessment

  • 4.1. Assessment of Government Funding for Next-generation Surgical Robotic Systems
  • 4.2. Analysis of NIH Funding for Next-generation Surgical Robotic Systems
  • 4.3. National Heart, Lung, and Blood Institute Leads the Funding for Next-generation Surgical Robotic Systems Technology Research
  • 4.4. Titan Medical Collaborates with Teleflex for Improving Patient Outcomes
  • 4.5. Medtronic and KARL STORZ Partner to Enhance Product Capabilities
  • 4.6. Johnson & Johnson Acquires Controlling Stake in Verb Surgical to Strengthen Surgical Portfolio
  • 4.7. J&J acquires Orthotaxy for Expanding Application for a Range of Orthopedic Surgery Procedures
  • 4.8. Application Analysis: Increasing Application Areas offer Lucrative Growth Opportunities for Companies Developing Next-generation Surgical Robotic Systems
  • 4.9. Assessment of Adoption of Next-generation Surgical Robots Globally
  • 4.10. China is the Innovation Hotbed for Next-generation Surgical Robotic Systems
  • 4.11. Supportive Government Policies to Boost Innovation for Next-generation Surgical Robots in China
  • 4.12. Patent Scenario-Key Patents for Next-generation Surgical Robots

5.0. Analyst Insights

  • 5.1. Improving the Adoption of Robotic Surgery through Lower Patient Hospitalization and Flexible Payment Models
  • 5.2. Strategic Recommendations

6.0. Key Industry Contacts

  • 6.1. Key Industry Contacts

7.0. Appendix

  • 7.1. Technical Readiness Levels
  • Legal Disclaimer